Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors.
- DOI
- 10.1016/j.lungcan.2026.109626
- Published
- 2026-09-17
- Container
- Lung Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109626,
title = {Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors.},
author = {Yamada A and Salman HA and Tanaka K and Kinoshita Y and Kawaguchi M and Takada Y and Yamao H and Iwasaki S and Shimoide T and Lee AD and Hayashi H and Enomoto A.},
year = {2026},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2026.109626},
url = {https://doi.org/10.1016/j.lungcan.2026.109626}
}RIS
TY - JOUR TI - Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors. AU - Yamada A AU - Salman HA AU - Tanaka K AU - Kinoshita Y AU - Kawaguchi M AU - Takada Y AU - Yamao H AU - Iwasaki S AU - Shimoide T AU - Lee AD AU - Hayashi H AU - Enomoto A. PY - 2026 JO - Lung Cancer DO - 10.1016/j.lungcan.2026.109626 UR - https://doi.org/10.1016/j.lungcan.2026.109626 ER -
APA
A, Y., HA, S., K, T., Y, K., M, K., Y, T., H, Y., S, I., T, S., AD, L., H, H., & A., E. (2026). Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors.. Lung Cancer. https://doi.org/10.1016/j.lungcan.2026.109626
Source records
- europe-pmc · retrieved 2026-09-25T17:09:50.533Z